Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1368 | 2018 |
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre … RD Lopes, RHM Furtado, AVS Macedo, B Bronhara, LP Damiani, ... The Lancet 397 (10291), 2253-2263, 2021 | 467 | 2021 |
Tofacitinib in patients hospitalized with Covid-19 pneumonia PO Guimarães, D Quirk, RH Furtado, LN Maia, JF Saraiva, MO Antunes, ... New England Journal of Medicine 385 (5), 406-415, 2021 | 446 | 2021 |
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy RD Lopes, PO Guimarães, BJ Kolls, DM Wojdyla, CD Bushnell, M Hanna, ... Blood, The Journal of the American Society of Hematology 129 (22), 2980-2987, 2017 | 104 | 2017 |
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial PO Guimarães, SD Pokorney, RD Lopes, DM Wojdyla, BJ Gersh, ... Clinical Cardiology 42 (5), 568-571, 2019 | 100 | 2019 |
Factors associated with Leptospira sp infection in a large urban center in northeastern Brazil JP Dias, MG Teixeira, MCN Costa, CMC Mendes, P Guimarães, MG Reis, ... Revista da Sociedade Brasileira de Medicina Tropical 40, 499-504, 2007 | 99 | 2007 |
Aspirin-free prasugrel monotherapy following coronary artery stenting in patients with stable CAD: the ASET pilot study N Kogame, PO Guimaraes, R Modolo, F De Martino, J Tinoco, EE Ribeiro, ... Cardiovascular Interventions 13 (19), 2251-2262, 2020 | 80 | 2020 |
Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary analysis of the TRANSLATE-ACS study PO Guimarães, A Krishnamoorthy, LA Kaltenbach, KJ Anstrom, MB Effron, ... JAMA cardiology 2 (7), 750-757, 2017 | 53 | 2017 |
Implementation of a Regional Network for ST‐Segment–Elevation Myocardial Infarction (STEMI) Care and 30‐Day Mortality in a Low‐to Middle‐Income City in Brazil: Findings From … NM Filgueiras Filho, GS Feitosa Filho, DJF Solla, FC Argôlo, ... Journal of the American Heart Association 7 (14), e008624, 2018 | 47 | 2018 |
Sex differences in clinical characteristics, psychosocial factors, and outcomes among patients with stable coronary heart disease: insights from the STABILITY (Stabilization of … PO Guimaraes, CB Granger, A Stebbins, K Chiswell, C Held, JS Hochman, ... Journal of the American Heart Association 6 (9), e006695, 2017 | 39 | 2017 |
Association between perivascular inflammation and downstream myocardial perfusion in patients with suspected coronary artery disease CH Nomura, AN Assuncao-Jr, PO Guimaraes, G Liberato, TC Morais, ... European Heart Journal-Cardiovascular Imaging 21 (6), 599-605, 2020 | 38 | 2020 |
Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting ERFL de Moraes, C Cirenza, RD Lopes, AC Carvalho, PO Guimaraes, ... European journal of internal medicine 67, 36-41, 2019 | 36 | 2019 |
Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose? PO Guimaraes, P Tricoci Expert opinion on pharmacotherapy 16 (13), 1983-1995, 2015 | 26* | 2015 |
Câncer e Doenças Cardiovasculares na pandemia de Covid-19 LT Kawahara, IBSS Costa, CCS Barros, GC Almeida, CS Bittar, SI Rizk, ... Arquivos Brasileiros de Cardiologia 115, 547-557, 2020 | 24 | 2020 |
Usefulness of antithrombotic therapy in patients with atrial fibrillation and acute myocardial infarction PO Guimaraes, P Zakroysky, A Goyal, RD Lopes, LA Kaltenbach, ... The American Journal of Cardiology 123 (1), 12-18, 2019 | 23 | 2019 |
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary … PO Guimarães, S Leonardi, Z Huang, L Wallentin, F Van de Werf, ... American Heart Journal 196, 28-35, 2018 | 17 | 2018 |
Practical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary care PO Guimarães, S Kaatz, RD Lopes International journal of general medicine, 283-291, 2015 | 17 | 2015 |
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin PO Guimarães, RD Lopes, JH Alexander, L Thomas, AS Hellkamp, ... Journal of Thrombosis and Thrombolysis 48, 27-34, 2019 | 13 | 2019 |
Association of standard clinical and laboratory variables with red blood cell distribution width PO Guimarães, JL Sun, K Kragholm, SH Shah, KS Pieper, WE Kraus, ... American heart journal 174, 22-28, 2016 | 13 | 2016 |
Patients with COVID‐19 who experience a myocardial infarction have complex coronary morphology and high in‐hospital mortality: Primary results of a nationwide angiographic study A Abizaid, CM Campos, PO Guimarães, JR Costa Jr, BAA Falcão, ... Catheterization and Cardiovascular Interventions 98 (3), E370-E378, 2021 | 12 | 2021 |